Lactate-driven pyrimidine synthesis promotes ferroptosis resistance in hepatocellular carcinoma.

Park MJ, Lee S, Kim DH, Kim MK, Jang BK, Yoon G, Park M, Jeong GH, Byun JK, Choi YK, Park KG

Open source

DOI
10.1186/s43556-026-00450-3
Published
2026 Apr 17
Container
Molecular biomedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s43556-026-00450-3,
  title = {Lactate-driven pyrimidine synthesis promotes ferroptosis resistance in hepatocellular carcinoma.},
  author = {Park MJ and Lee S and Kim DH and Kim MK and Jang BK and Yoon G and Park M and Jeong GH and Byun JK and Choi YK and Park KG},
  year = {2026},
  journal = {Molecular biomedicine},
  doi = {10.1186/s43556-026-00450-3},
  url = {https://doi.org/10.1186/s43556-026-00450-3}
}

RIS

TY  - JOUR
TI  - Lactate-driven pyrimidine synthesis promotes ferroptosis resistance in hepatocellular carcinoma.
AU  - Park MJ
AU  - Lee S
AU  - Kim DH
AU  - Kim MK
AU  - Jang BK
AU  - Yoon G
AU  - Park M
AU  - Jeong GH
AU  - Byun JK
AU  - Choi YK
AU  - Park KG
PY  - 2026
JO  - Molecular biomedicine
DO  - 10.1186/s43556-026-00450-3
UR  - https://doi.org/10.1186/s43556-026-00450-3
ER  - 

APA

MJ, P., S, L., DH, K., MK, K., BK, J., G, Y., M, P., GH, J., JK, B., YK, C., & KG, P. (2026). Lactate-driven pyrimidine synthesis promotes ferroptosis resistance in hepatocellular carcinoma.. Molecular biomedicine. https://doi.org/10.1186/s43556-026-00450-3

Source records